CVC  Northwell Ventures

https://www.northwell.edu/about/our-organizat ion/northwell-ventures





     Office Locations:

600 Community Drive, Suite 302
Manhasset, NY 11030
Phone: 516-321-8121

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Northwell Ventures was launched to advance medical technology and promote the development of Northwell Health enterprises by investing in novel ideas and business models across the healthcare landscape. The firm's target investment size varies by opportunity and stage with the capacity to contribute larger dollar amounts on a case-by-case basis. Northwell is agnostic to stage of financing, however, preference is in Seed, Series A, and Series B rounds. Key areas under Northwell Ventures include: Clinical / Non-Clinical Joint Venture, Corporate Development, Direct Equity Investments, Domestic / International Consulting, Internal, Product / Service Commercialization, Large Practice Acquisitions, and New Company Creation.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Adam Boll Vice President
    Richard Mulry Senior Vice President
    Robert Scoskie Managing Director
    Thomas Thornton Senior Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/15/2017


      Arterys


      CA


      $30,000,000


      Series B


      10/05/2017


      Vestagen


      FL


      $9,500,000


      


      05/17/2017


      Conversa Health


      CA


      $8,000,000


      Series A


      05/12/2017


      HealthReveal


      NY


      $500,000


      Series A Extension


     

    Portfolio companies include:


      Arterys
        web link


      Avizia
        web link


      Conversa Health
        web link


      HealthReveal
        web link


      Vestagen
        web link


      Vestagen Technical Textiles
        web link


     

    Recent News: